期刊文献+

医药企业透明化:从乐观到绝望 被引量:2

From Optimism to Disillusion about Commitment to Transparency in the Medico-Industrial Complex
下载PDF
导出
摘要 20世纪70年代中期,我和其他几位合作者尝试整合妊娠和分娩期间有关保健效果的证据。我们首先检索MEDLINE,纳入我们认为对分析足够可靠的对照试验研究,接着我们又逐页手检了70种杂志,回溯到1950年起发表的相关文章。我们找到约3500篇对照试验报告,在WHO的帮助下,80年代中期,我们在一本分类书目中发表了这些报告的索引。
出处 《中国循证医学杂志》 CSCD 2006年第9期617-621,共5页 Chinese Journal of Evidence-based Medicine
  • 相关文献

参考文献30

  • 1National Perinatal Epidemiology Unit.A Classified Bibliography of Controlled Trials In Perinatal Medicine 1940-1984.Oxford:Oxford University Press (for the World Health Organization),1985.
  • 2Simes RJ.Publication bias:the case for an international registry of clinical trials.JClin Oncology,1986; 4:1529 1541.
  • 3Hetherington J,Dickersin K,Chalmers I,et al.Retrospective and prospective identification of unpublished controlled trials:lessons from a survey of obstetricians and pediatricians.Pediatrics,1989;84:374-380.
  • 4Chalmers I.Under-reporting research is scientific misconduct.JAMA,1990; 263:1405-1408.
  • 5Hemminki E.Study of information submitted by drug companies to licensing authorities.BMJ,1980; 280:833-836.
  • 6Lock S,Wells F.Preface to the second edition.In:Lock S,Wells F,eds.Fraud and Misconduct In Medical Research.London:BMJ Publishing Group,1996:xi-xii.
  • 7Sykes R.Being a modern pharmaceutical company.BMJ,1998;317:1172.
  • 8Gibbs T,Wager E.Realities of trial registration:the Glaxo Wellcome experience.IntJPharmaceut Med,2000; 14:203-105.
  • 9Wager E,Field EA,Grossman L.Good Publication Practice for pharmaceutical companies.Curr Med Res Opinion,2003; 19:149-154.
  • 10http://www.gpp-guidelines.org

同被引文献1

引证文献2

二级引证文献350

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部